Trial Profile
Double blind randomized placebo controlled trial of Natrecor [nesiritide] in patients hospitalized for decompensated heart failure in the presence of a normal left ventricular ejection fraction
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 10 Aug 2007 New trial record.